Answered You can buy a ready-made answer or pick a professional tutor to order an original one.
Biopsychology - Take a look at this lecture by Karen L. Swartz, M.D. that was delivered during the John Hopkins 25th Annual Mood Disorders Research/Education Symposium entitled: Antidepressants &
Biopsychology -
Take a look at this lecture by Karen L. Swartz, M.D. that was delivered during the John Hopkins 25th Annual Mood Disorders Research/Education Symposium entitled: Antidepressants & the Placebo Controversies. https://www.youtube.com/watch?v=LAMyzmWvjJE
Use the APUS Online Library to look up information on a particular drug used to treat a neurological or psychiatric disorder. If you are unable to find material in the Library on the particular drug you select, you may use other credible online sources. Any additional sources used must be websites with scientifically grounded information. Avoid .org sites which are frequently established by persons suffering from the same disorder and/or their family members and can be important sources of support for those persons, but which may also contain unsubstantiated and personal perspective based information. Also avoid using pharmaceutical sites as your only source of information; while they may look scientific, they also are maintained by companies in the business of manufacturing and selling medications. WebMD is an example of a web source which contains scientifically grounded information about treatments for various disorders including neurological and psychiatric ones. The sources you use must be no more than 5 years old.
Report what you find for each of the categories below:
- The class of the drug
- The mechanism of action
- Receptor sites the drug targets
- The drug's main affect
- Unexpected effects and side effects and drug interactions
- Non-FDA uses of the drug
What aspects of these drugs were comforting to you? What aspects did you find concerning? Why?
- @
- 730 orders completed
- ANSWER
-
Tutor has posted answer for $10.00. See answer's preview
*********** exists ** * unit ** ************* referred to ** ********* serotonin ******** ******** ** ******** ** ********* *** volume ** ********* ***** ** a biological substance ** the ********* that ****** ** ******* ****** *********** ********* ** ******** ***** The ********* ** ****** of this ************ ** not ***** ******** *** it seems ** ** ******* to its ********** ** *** ******** ****** of ********* **** mechanism ******* **** *** drug ******** the ******** ** ********* at the **************** ********* *********** ** *** neural ******** ********* ********* ** ********* ** *** ***** autoreceptors *********** targets *** **** ********* *** chief ********* **************** receptors ** *** human ***** (Monteith ** ** ***** In addition fluvoxamine ****** ***** enteroceptor **** ** ************** cholinergic ************ ********** *** serotonergic labyrinth *** ****** ********* ****** ** that ** down-regulates ***** ************** ********* to ***** major ********** ************ ************* ******* ** *********** ******* skin ************* ******** of the face ****** lips ** ****** ***** discomforts *** ******** (Monteith ** ** ***** Furthermore fluvoxamine ******* produce ***** **** ******* **** as ******** ******** diarrhea dry mounts headaches ****** and ****** sweating *********** appears to ******** **** aspirin ********** *** ********** ******* The pills **** ***** with ***** prescriptions **** as ********* *********** ********* *** ********** ********* 23 ******** ***** In addition ************* ********** ********* *********** *** *********** *** also ***** to ********* **** *********** ********* ********** ********* ************ and ********* ************ ******** **** fluvoxamine *** **** *** **** ************** ********* fluvoxamine ***** as * *********** *** *** body **** ********* *********** in treating ********** **** ** ******* ******** *** ****** *** drug ** also not ********** ****** pregnancy *** ** its **** ** ******* ********** *********** **** ** *** ********** ******* possessed ** *********** ******* including *** power ** ****** ********** *** ****** In ******** other ********** aspects ** **** ****** include its ******* ** ******** ***** norepinephrine ********* *** ****** ** **** ***** abilities ***** ** individual to ***** ****** *** ******** (Wiginton ************ *** **** concerning ******* ** *********** its ***** develop critical ********** such as ****** ******** ******** insomnia ********* ***** ******** ********** *** ****** is **** this ********* ********** the ******** *** ********* ******** ** ** ********** ***** ********* and diarrhea can point ** a ******** ************************ * ***** ***** * ****** * comparison ** ********* psychiatric **** interactions **** *** **** *********** ******** ****************** Research275 366-372WigintonK (2021December 23) Advances ** ********* *** Major ********** ******** *****